508 related articles for article (PubMed ID: 33239109)
1. Increased circulating level of interleukin-6 and CD8
Yang PH; Ding YB; Xu Z; Pu R; Li P; Yan J; Liu JL; Meng FP; Huang L; Shi L; Jiang TJ; Qin EQ; Zhao M; Zhang DW; Zhao P; Yu LX; Wang ZH; Hong ZX; Xiao ZH; Xi Q; Zhao DX; Yu P; Zhu CZ; Chen Z; Zhang SG; Ji JS; Wang FS; Cao GW
Infect Dis Poverty; 2020 Nov; 9(1):161. PubMed ID: 33239109
[TBL] [Abstract][Full Text] [Related]
2. Clinical characteristics of 71 patients with coronavirus disease 2019.
Xiao M; Hou M; Liu X; Li Z; Zhao Q
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Jul; 45(7):790-796. PubMed ID: 32879082
[TBL] [Abstract][Full Text] [Related]
3. Abnormal immunity of non-survivors with COVID-19: predictors for mortality.
Zhao Y; Nie HX; Hu K; Wu XJ; Zhang YT; Wang MM; Wang T; Zheng ZS; Li XC; Zeng SL
Infect Dis Poverty; 2020 Aug; 9(1):108. PubMed ID: 32746940
[TBL] [Abstract][Full Text] [Related]
4. Clinical and Immune Features of Hospitalized Pediatric Patients With Coronavirus Disease 2019 (COVID-19) in Wuhan, China.
Wu H; Zhu H; Yuan C; Yao C; Luo W; Shen X; Wang J; Shao J; Xiang Y
JAMA Netw Open; 2020 Jun; 3(6):e2010895. PubMed ID: 32492165
[TBL] [Abstract][Full Text] [Related]
5. Epidemiological characteristics and clinical features of 32 critical and 67 noncritical cases of COVID-19 in Chengdu.
Zheng Y; Xu H; Yang M; Zeng Y; Chen H; Liu R; Li Q; Zhang N; Wang D
J Clin Virol; 2020 Jun; 127():104366. PubMed ID: 32302954
[TBL] [Abstract][Full Text] [Related]
6. Using IL-2R/lymphocytes for predicting the clinical progression of patients with COVID-19.
Hou H; Zhang B; Huang H; Luo Y; Wu S; Tang G; Liu W; Mao L; Mao L; Wang F; Sun Z
Clin Exp Immunol; 2020 Jul; 201(1):76-84. PubMed ID: 32365221
[TBL] [Abstract][Full Text] [Related]
7. Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease.
Liu W; Tao ZW; Wang L; Yuan ML; Liu K; Zhou L; Wei S; Deng Y; Liu J; Liu HG; Yang M; Hu Y
Chin Med J (Engl); 2020 May; 133(9):1032-1038. PubMed ID: 32118640
[TBL] [Abstract][Full Text] [Related]
8. Persistent lymphocyte reduction and interleukin-6 levels are independently associated with death in patients with COVID-19.
Xu Y; Wang N; Shen X; Liu X; Liu H; Liu Y
Clin Exp Med; 2023 Nov; 23(7):3719-3728. PubMed ID: 37310657
[TBL] [Abstract][Full Text] [Related]
9. Laboratory features of severe vs. non-severe COVID-19 patients in Asian populations: a systematic review and meta-analysis.
Ghahramani S; Tabrizi R; Lankarani KB; Kashani SMA; Rezaei S; Zeidi N; Akbari M; Heydari ST; Akbari H; Nowrouzi-Sohrabi P; Ahmadizar F
Eur J Med Res; 2020 Aug; 25(1):30. PubMed ID: 32746929
[TBL] [Abstract][Full Text] [Related]
10. Viral loads, lymphocyte subsets and cytokines in asymptomatic, mildly and critical symptomatic patients with SARS-CoV-2 infection: a retrospective study.
Yin SW; Zhou Z; Wang JL; Deng YF; Jing H; Qiu Y
Virol J; 2021 Jun; 18(1):126. PubMed ID: 34118952
[TBL] [Abstract][Full Text] [Related]
11. The timeline and risk factors of clinical progression of COVID-19 in Shenzhen, China.
Wang F; Qu M; Zhou X; Zhao K; Lai C; Tang Q; Xian W; Chen R; Li X; Li Z; He Q; Liu L
J Transl Med; 2020 Jul; 18(1):270. PubMed ID: 32620125
[TBL] [Abstract][Full Text] [Related]
12. CD4 and CD8 Lymphocyte Counts as Surrogate Early Markers for Progression in SARS-CoV-2 Pneumonia: A Prospective Study.
Calvet J; Gratacós J; Amengual MJ; Llop M; Navarro M; Moreno A; Berenguer-Llergo A; Serrano A; Orellana C; Cervantes M
Viruses; 2020 Nov; 12(11):. PubMed ID: 33182268
[TBL] [Abstract][Full Text] [Related]
13. Neutrophil-to-lymphocyte ratio, a critical predictor for assessment of disease severity in patients with COVID-19.
Liu L; Zheng Y; Cai L; Wu W; Tang S; Ding Y; Liu W; Kou G; Xiong Z; Wang S; Zheng S
Int J Lab Hematol; 2021 Apr; 43(2):329-335. PubMed ID: 33099889
[TBL] [Abstract][Full Text] [Related]
14. Clinical characteristics of 182 pediatric COVID-19 patients with different severities and allergic status.
Du H; Dong X; Zhang JJ; Cao YY; Akdis M; Huang PQ; Chen HW; Li Y; Liu GH; Akdis CA; Lu XX; Gao YD
Allergy; 2021 Feb; 76(2):510-532. PubMed ID: 32524611
[TBL] [Abstract][Full Text] [Related]
15. Risk factors associated with disease progression in a cohort of patients infected with the 2019 novel coronavirus.
Zhou Y; Zhang Z; Tian J; Xiong S
Ann Palliat Med; 2020 Mar; 9(2):428-436. PubMed ID: 32233642
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for redetectable positivity in recovered COVID-19 children.
Peng D; Zhang J; Ji Y; Pan D
Pediatr Pulmonol; 2020 Dec; 55(12):3602-3609. PubMed ID: 33049115
[TBL] [Abstract][Full Text] [Related]
17. Identification of risk factors for in-hospital death of COVID - 19 pneumonia -- lessions from the early outbreak.
Wang Z; Wang Z
BMC Infect Dis; 2021 Jan; 21(1):113. PubMed ID: 33494706
[TBL] [Abstract][Full Text] [Related]
18. The hemocyte counts as a potential biomarker for predicting disease progression in COVID-19: a retrospective study.
Zheng Y; Zhang Y; Chi H; Chen S; Peng M; Luo L; Chen L; Li J; Shen B; Wang D
Clin Chem Lab Med; 2020 Jun; 58(7):1106-1115. PubMed ID: 32352397
[TBL] [Abstract][Full Text] [Related]
19. Clinical Characteristics and Immune Injury Mechanisms in 71 Patients with COVID-19.
Wu Y; Huang X; Sun J; Xie T; Lei Y; Muhammad J; Li X; Zeng X; Zhou F; Qin H; Shao L; Zhang Q
mSphere; 2020 Jul; 5(4):. PubMed ID: 32669467
[TBL] [Abstract][Full Text] [Related]
20. Sex differences in immune responses to SARS-CoV-2 in patients with COVID-19.
Zhao G; Xu Y; Li J; Cui X; Tan X; Zhang H; Dang L
Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33350432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
